Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes

The complexity and overall burden of Parkinson’s disease (PD) require new pharmacological approaches to counteract the symptomatology while reducing the progressive neurodegeneration of affected dopaminergic neurons. Since the pathophysiological signature of PD is characterized by the loss of physio...

Descripción completa

Detalles Bibliográficos
Autores principales: Padilla-Godínez, Francisco J., Ruiz-Ortega, Leonardo I., Guerra-Crespo, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657131/
https://www.ncbi.nlm.nih.gov/pubmed/36359841
http://dx.doi.org/10.3390/cells11213445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657131/
https://www.ncbi.nlm.nih.gov/pubmed/36359841
http://dx.doi.org/10.3390/cells11213445

Ejemplares similares